Human Insulin Market Set for Rapid Growth between 2020 - 2026

The global human insulin market size is anticipated to reach USD 27.71 billion by 2026. International Diabetes Federation (IDF) reported that around 425 million people across the world suffer from diabetes. This shows that the rising prevalence of diabetes is propelling growth in the market. Fortune Business Insights in a new report, titled "Human Insulin Market Size, Share & Industry Analysis, By Type (Analogue Insulin (Long-Acting, Fast Acting, Premix), Traditional Human Insulin (Long-Acting, Short-Acting, Fast Acting, Premix)), By Diabetes Type (Type 1, Type 2), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy), and Regional Forecast, 2019-2026" predicts the market to exhibit a CAGR of 3.4% during the forecast period. In 2018, the market value stood at USD 21.26 billion in 2018. The adoption of delivery devices primarily for insulin administration is increasing, thus driving the market.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/human-insulin-market-100395

Eli Lilly & Company to Launch Analogue Humalog Insulin in the U.S.

Among products, analogue insulin covered the maximum part in the human insulin market share in 2018. Analogue insulin helps to control blood sugar levels in people suffering from type 1 and type 2 diabetes. Driven by this, the adoption of analogue insulin is increasing, which increases the human insulin market size. This, coupled with the recent launch of generic insulin, is expected to contribute to the growth of the market. For instance, Eli Lilly and Company announced the launch of a generic version of analogue Humalog insulin called Insulin Lispro in April 2019. Owing to the cheaper rates of Humalog, this insulin is more accessible to diabetic patients in the country. This segment is expected to drive the human insulin market in the foreseeable future.

Presence of Giant Insulin Manufacturers to Give Impetus to the Growth in North America

From a geographical standpoint, North America continues to maintain its dominance in the global human insulin market through the forecast years. The report indicates that the market in this region was worth USD 10.42 billion in the year 2018. The growth in the market is driven by the existence of key insulin manufacturers and robust competition among each other. In addition to this, the increasing prevalence of type 1 diabetes in North America is enabling growth in the market. The higher prices of insulin in the U.S. is likely to garner growth in the market, which in turn, will foster the human insulin market size in North America. Other factors driving the insulin drugs market in this region are increasing healthcare spending and rising research and development (R&D) activities for the successful development of biosimilars.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/human-insulin-market-100395

Apart from North America, Europe is the second-most leading region in the market. Following Europe, the market in Asia Pacific is expected to rise at the highest CAGR over the projected horizon. This is ascribable to the rising prevalence of diabetes, coupled with rising per capita income of the population in this region. Another factor driving the market is the higher availability of generic insulin. Other regions such as Latin America and the Middle East and Africa are expected to grow at a slow rate in the forthcoming years.

Novo Nordisk to Expand its Insulin Manufacturing Plant in India

The prevalence of diabetes is increasing across the world, one of the primary human insulin market trends. In a 2017 report published by the Centers for Diseases Control and Prevention (CDC), it was found that around 30.3 million people in the U.S. suffered from diabetes. Furthermore, it was stated that among the above numbers, around 23.1 million were diagnosed, while the rest were not diagnosed. The increasing adoption of a sedentary lifestyle is the primary reason behind the prevalence of diabetes. This, as a result, will fuel demand for insulin pens and insulin injections among masses. Consequently, Biocon plans to develop an oral insulin tablet called Tregopil for people suffering from Type 1 and Type 2 diabetes. This tablet aims to improve the post-prandial blood sugar control and has minimum side-effects. As per the report, companies such as Eli Lilly and Company, Sanofi, and Novo Nordisk A/S hold the maximum share in the global market.

Some of the other key players operating in the market are:

Novo Nordisk A/S
Eli Lilly and Company
Boston Scientific Corporation
Sanofi
Boehringer Ingelheim International GmbH
Biocon
Tonghua Dongbao Pharmaceutical
Julphar
Wockhard
Other prominent players
Several companies are focusing on to develop their product portfolio by targeting emerging or underdeveloped countries. For instance, Novo Nordisk plans to expand its manufacturing facility plant in Ahmedabad, India. This facility ensures the provision of high-quality quality and affordable insulin for diabetic patients.

Some of the industry developments made by companies are mentioned below:

April 2019: Eli Lily and Company to launch a low-priced insulin called Humalog in the U.S. to fulfil the needs of people who need insulin.

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/human-insulin-market-100395

Detailed Table of Content:

Introduction
Research Scope
Market Segmentation
Research Methodology
Definitions and Assumptions
Executive Summary
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Key Insights
Prevalence of Diabetes - Key Countries
Pipeline Analysis
Brand Analysis
Key Market Strategies of Leading Players
Overview of Regulatory Scenario - Key Countries
Global Human Insulin Market Analysis, Insights and Forecast, 2015-2026
Key Findings / Summary
Market Analysis, Insights and Forecast - By Type
Analogue Insulin
Long-acting
Fast-acting
Premix
Traditional Human Insulin
Long-acting
Short-acting
Fast-acting
Premix
Market Analysis, Insights and Forecast - By Diabetes Type
Diabetes Type 1
Diabetes Type 2
Market Analysis, Insights and Forecast - By Distribution Channel
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Market Analysis, Insights and Forecast - By Region
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
TOC Continued....!

Have a Look at Related Reports:

Sports Medicine Market Share, Size 2020 - https://www.medgadget.com/2020/02/sports-medicine-market-share-size-2020-global-industry-analysis-by-growth-trends-leaders-merger-revenue-statistics-opportunities-emerging-technologies-demand-competitive-and-regional-forecas.html

Ophthalmic Surgical Devices Market 2020 - https://www.medgadget.com/2020/02/ophthalmic-surgical-devices-market-2020-size-share-growth-trends-developments-leading-players-revenue-business-insights-competitive-landscape-with-regional-and-global-industry-forecast-to-2026.html

Population Health Management Market 2020 - https://www.medgadget.com/2020/02/population-health-management-market-2020-global-analysis-by-size-trends-share-growth-merger-solutions-leaders-competitive-landscape-regional-outlook-with-industry-forecast-to-2026.html

Cardiac Biomarkers Market - 2020 - https://www.medgadget.com/2020/02/cardiac-biomarkers-market-2020-size-trends-share-merger-growth-insight-revenue-key-players-competitive-analysis-regional-forecast-with-global-industry-outlook-to-2026.html

Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights(TM) we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Fortune Business Insights(TM) Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights(TM)
Linkedin | Twitter | BLogs

This release was published on openPR.